AAAAAA
Results:
1-20
|
Results: 20
Authors:
Auzary, C
Du Boutin, LTH
Wechsler, B
Chollet, P
Piette, JC
Citation: C. Auzary et al., Disseminated nocardiosis presenting as a flare of Behcet's disease, RHEUMATOLOG, 40(8), 2001, pp. 949-952
Authors:
Misset, JL
Vennin, P
Chollet, P
Pouillart, P
Laplaige, P
Frobert, JL
Castera, D
Fabro, M
Langlois, D
Cortesi, E
Lucas, V
Gamelin, E
Laadem, A
Otero, J
Citation: Jl. Misset et al., Multicenter phase II-III study of oxaliplatin plus cyclophosphamide vs. cisplatin plus cyclophosphamide in chemonaive advanced ovarian cancer patients, ANN ONCOL, 12(10), 2001, pp. 1411-1415
Authors:
Adenis, A
Bonneterre, J
Bonneterre, ME
Pion, JM
Vanlemmens, L
Gladieff, L
de Lafontan, B
Martel, P
Mihura, J
Roche, H
Gedouin, D
Kerbrat, P
Lesimple, T
Bremond, A
Devaux, Y
Delecroix, V
Fumoleau, P
Maugard-Louboutin, C
Namer, M
Goudier, MJ
Morice, F
Montcuquet, P
Schraub, S
Coudert, B
Fargeot, P
de Gislain, C
Mayer, F
Bastit, P
Chevallier, B
Grandgirard, A
Monnier, A
Sun, X
Clavere, P
Ollivier, JP
Rhein, B
Roullet, B
Datchary, J
Audhuy, B
Barats, JC
Kohser, F
Dides, S
Ramos, R
Cattan, A
Eymard, JC
Pourny, C
Weber, B
de Laroche, G
Pichon, A
Seffert, P
Hayat, M
Zambon, E
Chollet, P
Van Praagh, I
Citation: A. Adenis et al., Benefit of a high-dose epirubicin regimen in adjuvant chemotherapy for node-positive breast cancer patients with poor prognostic factors: 5-year follow-up results of French adjuvant study group 05 randomized trial, J CL ONCOL, 19(3), 2001, pp. 602-611
Authors:
Khayat, D
Chollet, P
Antoine, EC
Monfardini, S
Ambrosini, G
Benhammouda, A
Mazen, MF
Sorio, R
Borg-Olivier, O
Ramazeilles, C
Azli, N
Citation: D. Khayat et al., Phase II study of sequential administration of docetaxel followed by doxorubicin and cyclophosphamide as first-line chemotherapy in metastatic breastcancer, J CL ONCOL, 19(14), 2001, pp. 3367-3375
Authors:
Marchenay, C
Cellarier, E
Levi, F
Rolhion, C
Kwiatkowski, F
Claustrat, B
Madelmont, JC
Chollet, P
Citation: C. Marchenay et al., Circadian variation in O-6-alkylguanine-DNA alkyltransferase activity in circulating blood mononuclear cells of healthy human subjects, INT J CANC, 91(1), 2001, pp. 60-66
Authors:
Cure, H
Bay, JO
Plagne, R
Chollet, P
Dauplat, J
Citation: H. Cure et al., High-dose chemotherapy in advanced epithelial ovarian cancer, B CANCER, 88(9), 2001, pp. 842-851
Authors:
Bastit, P
Chevallier, B
Chevreau, C
Mihura, J
Roche, H
Namer, M
Gedouin, D
Kerbrat, P
Lesimple, T
Coudert, B
Fargeot, P
de Gislain, C
Mayer, F
Luporsi, E
Rios, M
Weber, B
Bremond, A
Devaux, Y
Monteuquet, P
Schraub, S
Hayat, M
Zambon, E
Grandgirard, A
Monnier, A
Sun, X
Clavere, P
Ollivier, JP
Rhein, B
Roullet, B
Chollet, P
Van Praagh, I
Cattan, A
Eymard, JC
Pourny, C
Facchini, T
Walter, S
Dides, S
Ramos, R
Guiochet, N
Seffert, P
Perpoint, X
Sztermer, JF
Cretin, J
Goudier, MJ
Morice, F
Delecroix, V
Fumoleau, P
Citation: P. Bastit et al., Epirubicin-based chemotherapy in metastatic breast cancer patients: Role of dose-intensity and duration of treatment, J CL ONCOL, 18(17), 2000, pp. 3115-3124
Authors:
Giacchetti, S
Perpoint, B
Zidani, R
Le Bail, N
Faggiuolo, R
Focan, C
Chollet, P
Llory, JF
Letourneau, Y
Coudert, B
Bertheaut-Cvitkovic, F
Larregain-Fournier, D
Le Rol, A
Walter, S
Adam, R
Misset, JL
Levi, F
Citation: S. Giacchetti et al., Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer, J CL ONCOL, 18(1), 2000, pp. 136-147
Authors:
Charrier, S
Chollet, P
Bay, JO
Cure, H
Kwiatkowski, F
Portefaix, G
Communal, Y
Betail, G
Plagne, R
Chassagne, J
Citation: S. Charrier et al., Hematological recovery and peripheral blood progenitor cell mobilization after induction chemotherapy and GM-CSF plus G-CSF in breast cancer, BONE MAR TR, 25(7), 2000, pp. 705-710
Authors:
Cure, H
Chevalier, V
Pezet, D
Bousquet, J
Focan, C
Levi, F
Garufi, C
Chipponi, J
Chollet, P
Citation: H. Cure et al., Phase II trial of chronomodulated infusion of 5-fluorouracil and folinic acid in metastatic colorectal cancer, ANTICANC R, 20(6C), 2000, pp. 4649-4653
Phase II trial of cystemustine, a new nitrosourea, as treatment of high-grade brain tumors in adults
Authors:
Roche, H
Cure, H
Adenis, A
Fargeot, P
Terret, C
Lentz, MA
Madelmont, JC
Fumoleau, P
Hanauske, A
Chollet, P
Citation: H. Roche et al., Phase II trial of cystemustine, a new nitrosourea, as treatment of high-grade brain tumors in adults, J NEURO-ONC, 49(2), 2000, pp. 141-145
Authors:
Cure, H
Dauplat, J
Chollet, P
Citation: H. Cure et al., First line chemotherapy for advanced ovarian cancer in 2000: standards andquestions, B CANCER, 87(2), 2000, pp. 189-199
Authors:
Coll, JL
Chollet, P
Brambilla, E
Desplanques, D
Behr, JP
Favrot, M
Citation: Jl. Coll et al., In vivo delivery to tumors of DNA complexed with linear polyethylenimine, HUM GENE TH, 10(10), 1999, pp. 1659-1666
Authors:
Cure, H
Souteyrand, P
Ouabdesselam, R
Roche, H
Ravaud, A
D'incan, M
Viens, P
Fargeot, P
Lentz, MA
Fumoleau, P
Hanauske, A
Chollet, P
Citation: H. Cure et al., Results of a phase II trial with cystemustine at 90 mg/m(2) as a first- orsecond-line treatment in advanced malignant melanoma: a trial of the EORTCClinical Studies Group, MELANOMA RE, 9(6), 1999, pp. 607-610
Authors:
Bonneterre, J
Spielman, M
Guastalla, JP
Marty, M
Viens, P
Chollet, P
Roche, H
Fumoleau, P
Mauriac, L
Bourgeois, H
Namer, M
Bergerat, JP
Misset, JL
Trandafir, L
Mahjoubi, M
Citation: J. Bonneterre et al., Efficacy and safety of docetaxel (Taxotere (TM)) in heavily pretreated advanced breast cancer patients: the French compassionate use programme experience, EUR J CANC, 35(10), 1999, pp. 1431-1439
Authors:
Schoffski, P
Chollet, P
Ganser, A
Wiese, KH
Rambusch, E
de Vries, MJ
Hanauske, A
Citation: P. Schoffski et al., Complete response of a gastric primary after a short but toxic course of 'S-1', ANN ONCOL, 10(9), 1999, pp. 1117-1120
Authors:
Le Bouedec, G
Charrier, S
Cure, H
de Latour, MP
Ferriere, JP
Chollet, P
Dauplat, J
Citation: G. Le Bouedec et al., Role for surgery after complete clinical response to neoadjuvant chemotherapy for breast cancer, PRESSE MED, 28(39), 1999, pp. 2145-2148
Authors:
Garufi, C
Dogliotti, L
Terzoli, E
Focan, C
Smaaland, R
Chollet, P
Perpoint, B
Levi, F
Citation: C. Garufi et al., Letter to the Editor, TUMORI, 85(2), 1999, pp. 149-150
Authors:
Rolhion, C
Penault-Llorca, F
Kemeny, JL
Kwiatkowski, F
Lemaire, JJ
Chollet, P
Finat-Duclos, F
Verrelle, P
Citation: C. Rolhion et al., O-6-methylguanine-DNA methyltransferase gene (MGMT) expression in human glioblastomas in relation to patient characteristics and p53 accumulation, INT J CANC, 84(4), 1999, pp. 416-420
Authors:
Levi, F
Zidani, R
Brienza, S
Dogliotti, L
Perpoint, B
Rotarski, M
Letourneau, Y
Llory, JF
Chollet, P
Le Rol, A
Focan, C
Citation: F. Levi et al., A multicenter evaluation of intensified, ambulatory, chronomodulated chemotherapy with oxaliplatin, 5-fluorouracil, and leucovorin as initial treatment of patients with metastatic colorectal carcinoma, CANCER, 85(12), 1999, pp. 2532-2540
Risultati:
1-20
|